Orlando, FL (PRWEB) November 19, 2013
The diabetes drug safety center at DrugNews.net is advising patients taking the medications Januvia or Janumet of updated information on the site. The latest court records show the number of patients alleging cancer from drugs like Januvia has grown in the past month*.
DrugNews was created to give those taking popular prescription drugs like Januvia and Janumet the latest product warnings, recalls, studies and legal news. Patients can avoid dangerous drugs, see if others are experiencing similar side effects and decide if they need legal advice.
The drug center has added expert health warnings that the popular diabetes meds Januvia and Janumet, sold by Merck, may be linked to cancer.
In 2011, researchers from UCLA discovered subjects given Januvia had increased risks of pancreatic cancer and thyroid cancer**.
In February, the American Medical Association advised diabetes drugs like Januvia can double the risk of pancreatitis, a major risk factor for pancreatic cancer***. DrugNews also learned of a study by the Institute for Safe Medication Practices finding indications in FDA reports that patients taking drugs like Januvia have elevated risks of pancreatic cancer****.
Due to the number of patients who have filed a Januvia lawsuit alleging cancer, cases have been consolidated to a special federal multidistrict litigation court. (In Re: Incretin-Based Therapies Products Liability Litigation, MDL 2452, Southern District of California).
Now, DrugNews has learned that the latest update from the Judicial Panel on Multidistrict Litigation shows 157 cases have been filed alleging cancer from Januvia, Janumet, Byetta or Victoza as of November 18*.
Anyone affected by cancer after taking Januvia or Janumet is encouraged to visit the DrugNews Center or speak with a lawyer about their legal options. However, due to the specialized nature of these cases, DrugNews only recommends lawyers who have already handled Januvia lawsuits.
For more information on the research, side effects and litigation news related to Januvia and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*Judicial Panel on Multidistrict Litigation, 11/18/13; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-November-18-2013.pdf
**Gastroenterology, July 2011; ctsi.ucla.edu/education/files/publicview/training/docs/FDA-analysis.pdf
***JAMA Internal Medicine, 2/25/13; archinte.jamanetwork.com/article.aspx?articleid=1656537
****ISMP QuarterWatch April, 2013; ismp.org/QuarterWatch/pdfs/2012Q3.pdf
Read the full story at http://www.prweb.com/releases/2013-januvia-lawsuit/updates-news/prweb11343958.htm.
Copyright©2012 Vocus, Inc.
All rights reserved